
    
      Patients with cutaneous melanoma, cutaneous melanoma metastases and benign melanocytic nevi
      were included in the study. Punch biopsies were harvested from the center of the tumors. The
      miRNA machinery components were detected by quantitative real-time reverse transcriptase
      polymerase chain reaction.
    
  